Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiun Hsu

Showing results (11-20 of 191) with videos related to

Pageof 20
Sort By:
Annals of Internal Medicine|July 22, 2009
Lamivudine and hepatitis B reactivationChiun Hsu, Ann-Lii Cheng, Pei-Jer Chen
Expert Review of Clinical Pharmacology|January 14, 2014
Sorafenib for the treatment of hepatocellular carcinoma across geographic regionsChiun Hsu, Ying-Chun Shen, Ann Lii Cheng
Hepatology International|July 15, 2020
Novel systemic therapy for hepatocellular carcinomaYawen Dong, Tsung-Hao Liu, Thomas Yau, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 20, 2004
Recent advances in non-surgical treatment for advanced hepatocellular carcinomaChiun Hsu, Jason Chia-Hsien Cheng, Ann-Lii Cheng
Seminars in Liver Disease|June 15, 2021
Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic PerspectivesYung-Yeh Su, Chia-Chen Li, Yih-Jyh Lin, et al.
Journal of Hepatology|December 10, 2025
Reply to: "Comment on "Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration""Chia-Lang Hsu, Yung-Yeh Su, Da-Liang Ou, et al.
Liver Cancer|May 31, 2022
AXL and MET in Hepatocellular Carcinoma: A Systematic Literature ReviewChih-Hung Hsu, Yi-Hsiang Huang, Shi-Ming Lin, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 3, 2004
Quality of life of lung cancer patients: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13Wei-Chu Chie, Chih-Hsin Yang, Chiun Hsu, et al.
Hepatology (Baltimore, Md.)|July 31, 2009
Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapyChiun Hsu, Shu-Chen Wei, Ann-Lii Cheng, et al.
Cancer Letters|August 30, 2005
CD24 expression is a prognostic factor in intrahepatic cholangiocarcinomaMin-Cheng Su, Chiun Hsu, Hsin-Lien Kao, et al.
Pageof 20

Showing results (11-20 of 191) with videos related to

Sort By:
Pageof 20
Annals of Internal Medicine|July 22, 2009
Lamivudine and hepatitis B reactivationChiun Hsu, Ann-Lii Cheng, Pei-Jer Chen
Expert Review of Clinical Pharmacology|January 14, 2014
Sorafenib for the treatment of hepatocellular carcinoma across geographic regionsChiun Hsu, Ying-Chun Shen, Ann Lii Cheng
Hepatology International|July 15, 2020
Novel systemic therapy for hepatocellular carcinomaYawen Dong, Tsung-Hao Liu, Thomas Yau, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 20, 2004
Recent advances in non-surgical treatment for advanced hepatocellular carcinomaChiun Hsu, Jason Chia-Hsien Cheng, Ann-Lii Cheng
Seminars in Liver Disease|June 15, 2021
Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic PerspectivesYung-Yeh Su, Chia-Chen Li, Yih-Jyh Lin, et al.
Journal of Hepatology|December 10, 2025
Reply to: "Comment on "Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration""Chia-Lang Hsu, Yung-Yeh Su, Da-Liang Ou, et al.
Liver Cancer|May 31, 2022
AXL and MET in Hepatocellular Carcinoma: A Systematic Literature ReviewChih-Hung Hsu, Yi-Hsiang Huang, Shi-Ming Lin, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 3, 2004
Quality of life of lung cancer patients: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13Wei-Chu Chie, Chih-Hsin Yang, Chiun Hsu, et al.
Hepatology (Baltimore, Md.)|July 31, 2009
Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapyChiun Hsu, Shu-Chen Wei, Ann-Lii Cheng, et al.
Cancer Letters|August 30, 2005
CD24 expression is a prognostic factor in intrahepatic cholangiocarcinomaMin-Cheng Su, Chiun Hsu, Hsin-Lien Kao, et al.
Pageof 20